This paper is in the following e-collection/theme issue:
RCTs - Protocols/Proposals (non-eHealth) (403)Published on in Vol 5, No 4 (2016): Oct-Dec

A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)
A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)
Authors of this article:
Nobuko Yamaguchi1
;
Sonoko Misawa2
;
Yasunori Sato3
;
Kengo Nagashima3
;
Kanako Katayama1
;
Yukari Sekiguchi2
;
Yuta Iwai2
;
Hiroshi Amino2
;
Tomoki Suichi2
;
Takanori Yokota4
;
Yoichiro Nishida4
;
Nobuo Kohara5
;
Koichi Hirata6
;
Kazutoshi Nishiyama7
;
Ichiro Yabe8
;
Ken-Ichi Kaida9
;
Norihiro Suzuki10
;
Hiroyuki Nodera11
;
Shoji Tsuji12
;
Haruki Koike13
;
Jun-Ichi Kira14
;
Hideki Hanaoka1
;
Susumu Kusunoki15
;
Satoshi Kuwabara2
;
JET-GBS Group4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15
There are currently no tweets available for this article within the specified range.